comparemela.com

Latest Breaking News On - Interdisciplinary conference on psychedelic research - Page 1 : comparemela.com

Cybin Inc : Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024

- Amir Inamdar, Chief Medical Officer, to appear on panel discussions on June 5 and June 8 - - Ellen James, Director, Clinical Development, to present abstract titled "SPL026 (DMT fumarate) in combination

Noord hollandUnited kingdomUnited statesKellen jamesGabriel fahelSamir inamdarExchange commissionHealth canadaClinical developmentInterdisciplinary conference on psychedelic researchDrug administrationCybin incChief medical officerMajor depressiveInterdisciplinary conferencePsychedelic research

European Conference To Host A Host Of Experts, Explore What s Ahead For Psychedelic Medicine

An inspiring engagement following the quickly developing technology of psychedelic meds

United statesJohns hopkins universityCity ofUnited kingdomMatthias liechtiJohns hopkinsPia dijkstraBill richardsRick doblinNatasha masonKelan thomasTorsten passieBob jesseSuresh sundramRosalind wattsMaryland psychiatric research center

Algernon NeuroScience and the Centre for Human Drug

VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT:.

Noord hollandUnited kingdomBritish columbiaChristopherj moreauRick strassmanAlgernon pharmaceuticals incConstraint induced movement therapyAlgernon pharmaceuticalsCentre for human drug researchSeyltx incInterdisciplinary conference on psychedelic researchCompany phaseAlgernon neuroscienceHuman drug researchInterdisciplinary conferencePsychedelic research

Cancer Patients Struggle to Access Psilocybin Before They Die

The legal fight to expand access to psilocybin has been gaining momentum in the US and Canada. Dying patients are leading the charge. But some remain concerned about the broader reach.

United statesThomas hartleLady justiceCory bookerRand paulSunil aggarwalThomasw prevoznikKathryn tuckerDavid yadenErinn baldeschwilerJohns hopkinsAbigail burroughsSpencer hawkswellInstitute in seattleDrug enforcement administrationInterdisciplinary conference on psychedelic research

Cybin Inc : Cybin to Participate in Upcoming Scientific and Investor Conferences

Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) ("Cybin" or the "Company"), a biopharmaceutical company focused on progressing Psychedelics to TherapeuticsTM, is pleased to announce its participation in

New yorkUnited statesNoord hollandUnited kingdomSan franciscoBill brennanSamir inamdarLeah gibsonDoug drysdaleGabriel fahelInvestor relations strategic communicationsIr strategic communicationsCybin incInterdisciplinary conference on psychedelic researchJefferies innovation in mental health summitPsychedelic research

vimarsana © 2020. All Rights Reserved.